PEPFAR/CDC awards CIDRZ USD25m “Lab Innovation for Excellence (LIFE)” Grant

/, CIDRZ FrontPage, Frontpage Article, In The Press, Latest News/PEPFAR/CDC awards CIDRZ USD25m “Lab Innovation for Excellence (LIFE)” Grant

PEPFAR/CDC awards CIDRZ USD25m “Lab Innovation for Excellence (LIFE)” Grant

We are proud to announce that following a highly competitive process, CIDRZ emerged successful and was recently awarded a new co-operative agreement to implement the “Scaling Up Lab Services for Viral Load and Early Infant Diagnosis Testing to Meet the 90/90/90 Goals” project otherwise known as Lab Innovation for Excellence (LIFE).

It is a great honor for our organization that the United States Government, through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and Centers for Disease Control and Prevention (CDC), has once again called on CIDRZ. Our selection demonstrates the central importance of CIDRZ within the health landscape in Zambia, and that we are considered a trusted and capable partner by all stakeholders.

LIFE is a USD 25 million five-year project that aims at improving lab hubs in four provinces – Eastern, Lusaka, Southern and Western Provinces. This grant will enable CIDRZ to further strengthen our model partnership with the Ministry of Health through which we work to build a strong and sustainable health system for the delivery of quality healthcare to Zambians and control of the HIV epidemic.

This project will work in the third 90: monitoring of clients on anti-retroviral therapy and this will be scaled up to ensure clients’ needs are met.

LIFE will work towards strengthening the health systems by:

  • improving sample courier networks
  • providing equipment and personnel
  • improving quality management systems and
  • providing stable power (green energy among them) at pre-analytical level
  • improving data flow from facility, to testing

We have received this grant due to the excellence of the CIDRZ Central Laboratory team which has made us competitive. Dr Ranjit Warrier is the Principal Investigator for this project


Dr Izukanji Sikazwe

CEO and Director

About the Author:

Leave A Comment